You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys Anti-SARS-CoV-2 IVD Elecsys® Anti-SARS-CoV-2 CPS_000273 09 203 095 190 9 203 095 190 09203095190 9203095190 09203095190 Anti-SARS-CoV-2 Elecsys cobas e 200 Elecsys Anti-SARS-CoV-2 07613336179451 Reagents, kits 200 tests cobas e 411/601/602 true 09 203 079 190 9 203 079 190 09203079190 9203079190 09203079190 Anti-SARS-CoV-2 Elecsys E2G 300 Elecsys Anti-SARS-CoV-2 07613336179444 Reagents, kits 300 tests cobas e 402/801 true 09203079500 Elecsys Anti-SARS-CoV-2 en 3 FF0000000425A40E FF000000040BDA0E 09203079190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys Anti‑SARS‑CoV‑2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‑CoV‑2) in human serum and plasma. The test is intended as an aid in the determination of the immune reaction to SARS‑CoV‑2.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09203079500 Elecsys Anti-SARS-CoV-2 en 4 FF00000004A01E0E FF00000004A01E0E 09203079190 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys Anti‑SARS‑CoV‑2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‑CoV‑2) in human serum and plasma. The test is intended as an aid in the determination of the immune reaction to SARS‑CoV‑2.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en